| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |